AP
Antipodes Partners Portfolio holdings
AUM
$4.76B
1-Year Est. Return
35.1%
This Fund
S&P 500
1 Year Est. Return
+35.1%
AUM
$4.46B
AUM Growth
+$1.23B
(+38%)
Holding
137
Top Buys
| 1 | +$167M | |
| 2 | +$156M | |
| 3 | +$137M | |
| 4 |
Sempra
SRE
|
+$136M |
| 5 |
Crown Castle
CCI
|
+$128M |
Top Sells
| 1 | +$108M | |
| 2 | +$91.6M | |
| 3 | +$63.5M | |
| 4 |
Johnson Controls International
JCI
|
+$58.9M |
| 5 |
Capital One
COF
|
+$53.6M |
Sector Composition
| 1 | Utilities | 29.1% |
| 2 | Healthcare | 12.44% |
| 3 | Technology | 11.97% |
| 4 | Financials | 8.08% |
| 5 | Materials | 7.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Micron Technology
MU
$414B
| – | – |
-403,540
|
|
||
127
Nutrien
NTR
$36.3B
| – | – |
-460,269
|
|
||
128
NovoCure
NVCR
$1.34B
| – | – |
-1,119
|
|
||
129
Pultegroup
PHM
$22.8B
| – | – |
-151,611
|
|
||
130
Qualcomm
QCOM
$140B
| – | – |
-10,086
|
|
||
131
Sabre
SABR
$605M
| – | – |
-87,855
|
|
||
132
Similarweb
SMWB
$240M
| – | – |
-17,510
|
|
||
133
ARS Pharmaceuticals
SPRY
$842M
| – | – |
-2,201
|
|
||
134
AT&T
T
$203B
| – | – |
-324,832
|
|
||
135
Vertex Pharmaceuticals
VRTX
$115B
| – | – |
-241
|
|
||
136
Full Truck Alliance
YMM
$8.64B
| – | – |
-68,035
|
|
||
137
GE Vernova
GEV
$244B
| – | – |
-34,137
|
|